Minimally invasive aortic valve bypass benefits high-risk elderly patientsSeptember 22, 2008Study: Valve bypass is a safe, effective alternative to valve replacement An uncommonly used surgical procedure that bypasses a narrowed aortic valve, rather than replacing it, effectively restores blood flow from the heart to the rest of the body and gives high-risk patients a safe alternative to conventional valve surgery. That is the finding of a study conducted at the University of Maryland Medical Center in Baltimore. The researchers conclude that the procedure, called aortic valve bypass, is an important treatment option for high-risk elderly patients with a narrowed aortic valve, a condition called aortic stenosis. The bypass procedure can be performed in a minimally invasive way without stopping the heart. Many of the patients in the study had previously been considered too frail to benefit from surgery. The study will appear in the September 30, 2008 print issue of Circulation and is now online.
"Because of the possible risks associated with aortic valve replacement in the elderly, almost 60 percent of patients with symptoms related to aortic stenosis are never referred to surgery," says the study's principal investigator, James S. Gammie, M.D., associate professor of surgery at the University of Maryland School of Medicine and cardiac surgeon at the University of Maryland Medical Center. Survival for these patients without surgery is poor; only 20 percent are alive three years after diagnosis. "But our research and five years of experience with the bypass procedure suggests there is a group of patients, typically considered inoperable because they are at the upper level of the risk spectrum, who could benefit from aortic valve bypass," says Dr. Gammie. The aortic valve controls the flow of blood from the heart's main pumping chamber, the left ventricle, to the aorta, the artery that supplies blood to the rest of the body. In aortic stenosis, calcium deposits narrow the valve and impair the heart's ability to pump blood. Aortic stenosis is the most common heart valve disease of the elderly in the United States. More than 50,000 people in the United States require surgery for aortic stenosis each year. During conventional valve replacement, the surgeon opens the chest, stops the heart for about 90 minutes, opens the aorta just above the aortic valve, cuts out the old valve and sews in a new one. While valve replacement has benefited millions of patients with good outcomes, in elderly patients, particularly those with other health conditions, the death rate can exceed 10 percent. The bypass procedure In order to bypass the narrowed aortic valve, surgeons at the University of Maryland Medical Center have refined a procedure, originally called an apicoaortic conduit, which was developed in the 1970s and initially used for children. During the procedure, most of the blood flow from the heart is diverted through a tube containing a standard replacement valve that is placed near the apex of the left ventricle, the pointed tip at the bottom of the heart, to the aorta, the main blood vessel at the back of the chest. The surgeons work through an incision between two ribs on the left side of the chest. During the first cases, a large incision was needed. However, the procedure was modified this year, so that only a small, three-inch opening between the ribs is required. "We are excited because for the first time we can surgically treat a narrowed aortic valve through a minimally-invasive approach with the heart beating, compared to the traditional breastbone-splitting approach," says Dr. Gammie. Study details Between 2003 and 2007, the surgeons treated 31 high-risk aortic stenosis patients with aortic valve bypass surgery. Many of the patients also had other conditions ranging from chronic obstructive pulmonary disease to kidney disease, or had a history of heart attack or diabetes. The average age was 81, and nearly half had been refused conventional surgery. Early in the series, four of the 31 patients did not survive the procedure, yet there were no deaths among the most recent 16 consecutive patients. The procedure was as effective as conventional aortic valve replacement surgery at relieving the obstruction of blood leaving the heart. Stroke and kidney problems were uncommon. Because the impaired aortic valve was left in place, some blood flow continued through that valve. But postsurgical blood flow measurements indicated that in most patients, approximately 70 percent of cardiac output flowed through the new bypass. The study results suggest that continued improvements in technology and surgical technique may warrant extending aortic valve bypass surgery to moderate-risk patients with aortic stenosis. In addition to the 31 patients who received an aortic valve bypass, the University of Maryland Medical Center performed 438 other aortic valve procedures during the same time period. University of Maryland Medical Center | |||||||||||||||||||||
|
Related Aortic Valve Current Events and Aortic Valve News Articles Percutaneous valve therapy: is it safe and effective? Researchers at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation (CRF), will present new studies evaluating a rapidly advancing field within interventional cardiology: percutaneous procedures to repair and replace defective heart valves. Link between obesity and enlarged heart discovered by University of Arizona researchers New research from The University of Arizona Sarver Heart Center helps explain why excessive body weight increases the risk for heart disease. Use of hydrocortisone reduces incidence of atrial fibrillation after cardiac surgery Patients who receive corticosteroids after cardiac surgery have a significantly lower risk of atrial fibrillation in the days following the surgery. New ACC/AHA guidelines released for valvular heart disease An updated set of guidelines jointly released by the American College of Cardiology (ACC) and the American Heart Association (AHA) draws together the latest information on the diagnosis and treatment of patients with valvular heart disease. Experience backs early heart valve replacement Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop. Percutaneous aortic valve replacement Percutaneous aortic valve replacement is becoming a reality and brings new hope for a number of patients who cannot currently be treated with traditional surgical techniques. ESC Congress 2003: Lipid-lowering therapy for valve prostheses IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: In our study we have demonstrated that lipid-lowering drugs (statins) can reduce the process of degeneration of the bioprosthetic aortic valves. Aortic valve replacement is one of the most often performed cardiac surgery procedures nowadays: 70 people per million of the general population undergo aortic valve replacement in the UK each year, a rate that is fairly common in the developed world. Two main types of valve prosthesis are a ESC Congress 2003: C-reactive protein, an inflammatory biomarker, predicts progression of aortic valve stenosis IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology Aortic stenosis (AS) is the narrowing or obstruction of the heart's aortic valve, which prevents it from opening properly and blocks the flow of blood from the left ventricle to the aorta. AS is common in the ageing population and has become the most frequent native valve disease in Europe. AS when severe, may cause left heart failure, fainting or angina, but the natural progression of less severe degrees is highly variable. The risk factors for the d Brain-damage Threat From Invasive Assessment Of Heart-valve Stenosis (p 1241) Authors of a study in this week's issue of THE LANCET warn against the widespread use of catheterisation to assess the extent of aortic-valve stenosis--this invasive procedure could increase the risk of cerebral blood clotting and brain damage. The severity of valvular aortic stenosis (a narrowing of the valve between the left ventricle of the heart and the aorta) can be accurately assessed non-invasively by echocardiography. However, retrograde catheterisation of the aortic valve is often undertaken to assess the degree of stenosis, especially for patients awaiting valve replacement; this procedure has a potential risk of neurological complications, with an unknown incidence of asymptomati Low-risk balloon trip to the heart Patients who are at high-risk of having a heart attack or who require a bypass must undergo a coronary angiography. A new balloon catheter, being presented at the MEDTEC exhibition, allows this to be done more swiftly, more easily and with less risk than previous examinations. Calcium and cholesterol can block coronary blood vessels. The thicker these blockages, the harder it becomes for blood to circulate through the heart muscle. A physician will perform a coronary angiography to be able to identify this lurking danger: a thin tube is inserted into the main artery through an incision in the groin and pushed along a guiding wire until it reaches the aortic valve at the entrance to the heart More Aortic Valve Current Events and Aortic Valve News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||